New oral disease-modifying therapies for multiple sclerosis

por Bagert, Bridget A, Bourdette, Dennis
Publicado 2009

Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges

por Su, Kimmy, Bourdette, Dennis, Forte, Michael
Publicado 2012

Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases

por Fang, Cheng, Bourdette, Dennis, Banker, Gary
Publicado 2012

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis

por Su, Kimmy, Bourdette, Dennis, Forte, Michael
Publicado 2013

Recent developments in multiple sclerosis therapeutics

por Spain, Rebecca I, Cameron, Michelle H, Bourdette, Dennis
Publicado 2009

Falls in People with Multiple Sclerosis Compared with Falls in Healthy Controls

por Mazumder, Rajarshi, Murchison, Charles, Bourdette, Dennis, Cameron, Michelle
Publicado 2014

Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex Measures

por Cameron, Michelle H., Thielman, Emily, Mazumder, Rajarshi, Bourdette, Dennis
Publicado 2013

Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients

por Bourdette, Dennis N., Hartung, Daniel M., Whitham, Ruth H.
Publicado 2016

Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS

por Bittner, Frank, Murchison, Charles, Koop, Dennis, Bourdette, Dennis, Spain, Rebecca
Publicado 2017

A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial

por Hugos, Cinda L, Bourdette, Dennis, Chen, Yiyi, Chen, Zunqiu, Cameron, Michelle
Publicado 2017

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

por Hartung, Daniel M., Bourdette, Dennis N., Ahmed, Sharia M., Whitham, Ruth H.
Publicado 2015

Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling

por Salinthone, Sonemany, Yadav, Vijayshree, Schillace, Robynn V., Bourdette, Dennis N., Carr, Daniel W.
Publicado 2010

Autoantibodies and Sjogren’s Syndrome in Multiple Sclerosis, a Reappraisal

por Solomon, Andrew J., Hills, William, Chen, Zunqiu, Rosenbaum, James, Bourdette, Dennis, Whitham, Ruth
Publicado 2013

Minocycline-associated vasculitis of extracranial branches of vertebral arteries presenting as myelopathy

por Garg, Neha, Altowaijri, Gadah H., Nesbit, Gary M., Gultekin, Sakir Humayun, Bourdette, Dennis N.
Publicado 2014

Enlarged perivascular spaces are not associated with vascular co-morbidities, clinical outcomes, and brain volumes in people with secondary progressive multiple sclerosis

por Wooliscroft, Lindsey, Boespflug, Erin, Hildebrand, Andrea, Shangraw, Kathleen, Silbermann, Elizabeth, Bourdette, Dennis, Spain, Rebecca
Publicado 2020

Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study

por Shinto, Lynne, Marracci, Gail, Mohr, David C., Bumgarner, Lauren, Murchison, Charles, Senders, Angela, Bourdette, Dennis
Publicado 2016

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin

por Hartung, Daniel M., Johnston, Kirbee, Cohen, David M., Nguyen, Thuan, Deodhar, Atul, Bourdette, Dennis N.
Publicado 2018

Mapping human brain capillary water lifetime: high‐resolution metabolic neuroimaging

por Rooney, William D., Li, Xin, Sammi, Manoj K., Bourdette, Dennis N., Neuwelt, Edward A., Springer, Charles S.
Publicado 2015

Sex-dependent treatment of chronic EAE with partial MHC class II constructs

por Benedek, Gil, Chaudhary, Priya, Meza-Romero, Roberto, Calkins, Evan, Kent, Gail, Offner, Halina, Bourdette, Dennis, Vandenbark, Arthur A.
Publicado 2017

Gray matter blood‐brain barrier water exchange dynamics are reduced in progressive multiple sclerosis

por Tagge, Ian J, Anderson, Valerie C, Springer, Charles S, Sammi, Manoj K, Bourdette, Dennis N, Spain, Rebecca I, Rooney, William D
Publicado 2021